Abbott Laboratories Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 11.16B | 11.46B | 11.37B | 11.14B | 10.36B | 10.97B | 10.63B | 10.38B |
| Cost of Goods Sold | 4.88B | 4.92B | 5.03B | 4.85B | 4.91B | 5.38B | 5.21B | 5.07B |
| Gross Profit | 6.28B | 6.54B | 6.34B | 6.29B | 5.44B | 5.60B | 5.43B | 5.30B |
| R&D Expenses | 756.0M | 735.0M | 785.0M | 732.0M | 703.0M | 728.0M | 713.0M | 697.0M |
| Operating Expenses | 4.44B | 4.29B | 4.31B | 4.24B | 3.76B | 3.61B | 3.61B | 3.62B |
| Operating Income | 1.84B | 2.25B | 2.06B | 2.05B | 1.69B | 1.99B | 1.82B | 1.69B |
| Other Income / Gains | -393.0M | 107.0M | 123.0M | 98.0M | 90.0M | 40.0M | 122.0M | -79.0M |
| Net Income | 1.08B | 1.78B | 1.64B | 1.78B | 1.32B | 9.23B | 1.65B | 1.30B |
| EPS (Diluted) | 0.62 | 1.02 | 0.94 | 1.02 | 0.758 | 5.33 | 0.95 | 0.75 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.563 | 0.57 | 0.557 | 0.564 | 0.526 | 0.51 | 0.51 | 0.511 |
| General And Administrative Expenses | 0 | 3.13B | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 3.26B | 3.13B | 3.10B | 3.09B | 3.05B | 2.88B | 2.90B | 2.92B |
| Other Expenses | 422.0M | 422.0M | 420.0M | 411.0M | 0 | 0 | 0 | 0 |
| Cost And Expenses | 9.32B | 9.21B | 9.31B | 9.09B | 8.67B | 8.98B | 8.82B | 8.69B |
| Interest Income | 0 | 0 | 77.0M | 71.0M | 82.0M | 91.0M | 91.0M | 82.0M |
| Interest Expense | 68.0M | 42.0M | 44.0M | 121.0M | 134.0M | 152.0M | 166.0M | 168.0M |
| Depreciation And Amortization | 0 | 422.0M | 791.0M | 777.0M | 756.0M | 807.0M | 801.0M | 805.0M |
| Ebitda | 1.84B | 2.82B | 3.09B | 3.05B | 2.67B | 2.99B | 2.91B | 2.58B |
| Ebitdaratio | 0.165 | 0.246 | 0.272 | 0.274 | 0.258 | 0.272 | 0.273 | 0.249 |
| Operating Income Ratio | 0.165 | 0.196 | 0.181 | 0.184 | 0.163 | 0.181 | 0.171 | 0.162 |
| Income Before Tax | 1.45B | 2.36B | 2.18B | 2.15B | 1.78B | 2.03B | 1.94B | 1.61B |
| Income Before Tax Ratio | 0.13 | 0.206 | 0.192 | 0.193 | 0.172 | 0.185 | 0.182 | 0.155 |
| Income Tax Expense | 372.0M | 582.0M | 536.0M | 371.0M | 453.0M | -7.20B | 294.0M | 305.0M |
| Net Income Ratio | 0.096 | 0.155 | 0.145 | 0.16 | 0.128 | 0.841 | 0.155 | 0.125 |
| Epsdiluted | 0.62 | 1.02 | 0.94 | 1.01 | 0.758 | 5.27 | 0.94 | 0.74 |
| Weighted Average Shs Out | 1.75B | 1.75B | 1.75B | 1.74B | 1.75B | 1.73B | 1.73B | 1.73B |
| Weighted Average Shs Out Dil | 1.75B | 1.75B | 1.75B | 1.75B | 1.75B | 1.75B | 1.75B | 1.75B |